-
This is a major acquisition and just less than a couple weeks ago Cardinal purchased Kinray in New York for 1.3 billion who is a leading pharmaceutical distributor that services over 2000 independent drug stores. The press release continues to state that by 2015 that China will be the second largest...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Nov 30 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, Medical Devices, Pharma, clinical trials, Cardinal Healthcare, acquisitions and mergers, pharmaceutial sales, Zuellig Pharma
-
Fighting skin cancer and finding the targets for drug development is not an easy task and UCLA released their recent findings on how they are working to find solutions for cancers that become resistant after a period of time. As you can read further in the press release, one experimental drug offered...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Nov 25 2010
Filed under:
Filed under: Medically Related, Other Items of Interest, drugs, Cancer, clinical trials, Research, Science, Disease, Patients, skin cancer, melanoma, UCLA, UCLA Jonsson Cancer Center, targets, tissues
-
Today we get to recognize and look at some other good things going in the State of Arizona beside the web chatter about their governor, something that can make a difference and save lives. One of the dream teams from Stand up to Cancer is located in Phoenix, TGEN who are working on and studying...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sun, Sep 19 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, personalized medicine, drugs, healthcare, Cancer, clinical trials, Patient, Grants, R and D, Stand up to Cancer, TGEN, ASU, Quintiles
-
An informed consent is what you sign to begin participation in a trial. This goes over your rights and gives you the benefits and risks of a trial. As Dan says, 25 pages or longer can be required. Next Dan goes over the 3 most important areas in the video below. Institutional...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Jun 2 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, FDA, clinical trials, Study, ethics, healthcare reform certification, informed consent
-
All enrolled had chronic hepatitis C infections and had never been treated for the disease. As noted the cure right now with standard therapies is stated to be worse than the cure, thus many did not want to endure flu like symptoms for an entire year. It appears here the time needed to take Telaprevir...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, May 25 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, clinical trials, Treatment, virus, Hepatitis C, enzyme, cure, Vertex
-
There’s a lot prostate cancer news today from the FDA. Provenge from Dendreon is a process to where blood is taken, send to Dendreon and injected back to the patient, using their own immune system to battle and extend life. In a prior post I went into detail about the process and how it works...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Apr 29 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Biotech, FDA, clinical trials, Prostate Cancer, Vaccine, Fast Track, Dendreon, Provenge, Prostvac, poxviral, research and developement, Bavarian Nordic
-
The news this week on prostate cancer drugs is heating up a bit. Prostvac from Bavarian Nordic is a vaccine that is given to extend the life of prostate cancer patients and the estimated life extension time is stated to be 8 months. Also this week is the expected approval of Provenge from...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Apr 29 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Biotech, FDA, clinical trials, Prostate Cancer, Vaccine, Fast Track, Prostvac, poxviral, research and developement, Bavarian Nordic
-
We are definitely on the search to find out what medications work and why. Just yesterday I posted about another company that is incorporating genomic research to match drugs, patients and price. Matching the Right Drugs to the Right Patient for the Right Price – Gene Network Algorithm Solutions...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Apr 28 2010
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, Medicine, drugs, healthcare, Prescriptions, clinical trials, Patients, Data, Algorithms, healthcare reform, chronic condition, phyicians
-
We talk about super computing on Wall Street and I mention occasionally how this technology slips over to healthcare and here’s one prime example. Obviously with risk management with health insurers, this would appear to be a company they would consider watching. Already major pharma companies...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Apr 27 2010
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, personalized medicine, drugs, healthcare, Pharma, clinical trials, Congress, Pfizer, Johnson and Johnson, Investing, Wall Street, Patients, pharmacy benefit managers, High Frequency Healthcare, Gene Network Sciences, GNS, PBM
-
How does it feel to be in a trial? This video touches on some of the good and bad and the communication between the patient and the site. Dan talks about documentation that might be missing, like missing some adverse affects of the drug in the trial. He makes a good point that as a site manager...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Apr 23 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, PHR, Google Health, FDA, clinical trials, Personal Health Records, HealthVault, Data, TrialX.org, morality, communications, lab rat, credibility
-
It certainly appears that business intelligence algorithms in healthcare are at an all time high today, and we have more data to analyze and study than every before as well. Phase Forward has a suite of software solutions extending beyond just clinical trial data. I talk quite a bit about...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Apr 16 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, personalized medicine, drugs, Health IT, clinical trials, Heatlhcare, Research and Development, Life Sciences, wireless, Data, Oracle, devices that report data, Phase Forward
-
Instead of being done in house, Thermo Fisher will be the outsourced agent here for materials, packaging and labeling products used in trials. Lilly employees can apply for jobs at Thermo Fisher as they are released from the company. Clinical trials are not getting any cheaper to put on and...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Mar 29 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, drugs, healthcare, Pharma, clinical trials, Research and Development, Outsourcing, Cost, devices that report data, Thermo Fisher, El Lilly
-
You know I recently asked a doctor if he knew what the cost for Viagra was, he had no clue, he just prescribes it and hands out samples. Not too long ago I posted about what Viagra costs too. What Does Viagra Cost? Ok let’s do some math here, at $15.00 approximately a pill, an average prescription...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Jan 11 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, Viagra, Prescriptions, clinical trials, Marketing, ED, Cost, Cialis
-
A total of 50 men is the target for enrollment. If this works Viagra could be in danger. We keep seeing more and more devices being developed to take the place of drugs and this is one more. Here’s a device in the works to take the place of Warfarin, the blood thinner for one example...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Tue, Oct 13 2009
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, drugs, healthcare, clinical trials, Stents, Medtronics, ED, erectile dysfunction, interventional devices
-
RNA-based aptamer technology is a new approach to make safer drugs, and allows for the creation of the drug along with the antidote at the same time. In this article, blood thinning agents are used as an example. Blood thinning agents are one of the most difficult classes of drugs to coordinate...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sun, Oct 4 2009
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, drugs, healthcare, Proteins, Pharma, Biotech, clinical trials, warfarin, Pharmacogenomics, Research and Development, molecular drug data, The Watchman, Aptamer, nucleic acid